Game-Changer in Atopic Dermatitis Care: Abrocit...

By Charmi Patel

July 9, 2024

Introduction: Atopic dermatitis (AD) presents a significant health challenge, impacting about 10% of Japan's population across all ...
The Role of Real-World Evidence in CMS Price Negotiations
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Insights into Austria’s Pricing and Pharmaceutical Policy
COPD Management: Evidence Report on Ensifentrine
Economics in Clinical Trials: A Guide to Value-Based Decisions